Literature DB >> 17264230

Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia.

Stella P Kim1, Karyn J Catalano, Isabel R Hsu, Jenny D Chiu, Joyce M Richey, Richard N Bergman.   

Abstract

Obesity is strongly associated with hyperinsulinemia and insulin resistance, both primary risk factors for type 2 diabetes. It has been thought that increased fasting free fatty acids (FFA) may be responsible for the development of insulin resistance during obesity, causing an increase in plasma glucose levels, which would then signal for compensatory hyperinsulinemia. But when obesity is induced by fat feeding in the dog model, there is development of insulin resistance and a marked increase in fasting insulin despite constant fasting FFA and glucose. We examined the 24-h plasma profiles of FFA, glucose, and other hormones to observe any potential longitudinal postprandial or nocturnal alterations that could lead to both insulin resistance and compensatory hyperinsulinemia induced by a high-fat diet in eight normal dogs. We found that after 6 wk of a high-fat, hypercaloric diet, there was development of significant insulin resistance and hyperinsulinemia as well as accumulation of both subcutaneous and visceral fat without a change in either fasting glucose or postprandial glucose. Moreover, although there was no change in fasting FFA, there was a highly significant increase in the nocturnal levels of FFA that occurred as a result of fat feeding. Thus enhanced nocturnal FFA, but not glucose, may be responsible for development of insulin resistance and fasting hyperinsulinemia in the fat-fed dog model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264230     DOI: 10.1152/ajpendo.00669.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  54 in total

1.  Large size cells in the visceral adipose depot predict insulin resistance in the canine model.

Authors:  Morvarid Kabir; Darko Stefanovski; Isabel R Hsu; Malini Iyer; Orison O Woolcott; Dan Zheng; Karyn J Catalano; Jenny D Chiu; Stella P Kim; Lisa N Harrison; Viorica Ionut; Maya Lottati; Richard N Bergman; Joyce M Richey
Journal:  Obesity (Silver Spring)       Date:  2011-08-11       Impact factor: 5.002

2.  Topical KINOSTAT™ ameliorates the clinical development and progression of cataracts in dogs with diabetes mellitus.

Authors:  Peter F Kador; Terah R Webb; Dineli Bras; Kerry Ketring; Milton Wyman
Journal:  Vet Ophthalmol       Date:  2010-11       Impact factor: 1.644

Review 3.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

4.  Activation of NPRs and UCP1-independent pathway following CB1R antagonist treatment is associated with adipose tissue beiging in fat-fed male dogs.

Authors:  Malini S Iyer; Rebecca L Paszkiewicz; Richard N Bergman; Joyce M Richey; Orison O Woolcott; Isaac Asare-Bediako; Qiang Wu; Stella P Kim; Darko Stefanovski; Cathryn M Kolka; Deborah J Clegg; Morvarid Kabir
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-06-25       Impact factor: 4.310

5.  NEFA minimal model parameters estimated from the oral glucose tolerance test and the meal tolerance test.

Authors:  Ray C Boston; Peter J Moate
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-18       Impact factor: 3.619

6.  Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study.

Authors:  N D Palmer; C D Langefeld; J T Ziegler; F Hsu; S M Haffner; T Fingerlin; J M Norris; Y I Chen; S S Rich; T Haritunians; K D Taylor; R N Bergman; J I Rotter; D W Bowden
Journal:  Diabetologia       Date:  2009-11-10       Impact factor: 10.122

7.  Insulin access to skeletal muscle is impaired during the early stages of diet-induced obesity.

Authors:  Josiane L Broussard; Ana V B Castro; Malini Iyer; Rebecca L Paszkiewicz; Isaac Asare Bediako; Lidia S Szczepaniak; Edward W Szczepaniak; Richard N Bergman; Cathryn M Kolka
Journal:  Obesity (Silver Spring)       Date:  2016-09       Impact factor: 5.002

Review 8.  Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.

Authors:  Mi-Jeong Lee; Yuanyuan Wu; Susan K Fried
Journal:  Mol Aspects Med       Date:  2012-10-13

9.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

10.  Diet-induced obesity prevents interstitial dispersion of insulin in skeletal muscle.

Authors:  Cathryn M Kolka; L Nicole Harrison; Maya Lottati; Jenny D Chiu; Erlinda L Kirkman; Richard N Bergman
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.